GRAL insider trading
NasdaqGS HealthcareGRAIL, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About GRAIL, Inc.
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
Company website: grail.com
GRAL insider activity at a glance
FilingIQ has scored 107 insider transactions for GRAL since Jun 24, 2024. The most recent filing in our index is dated Apr 15, 2026.
Across the full history, 4 open-market purchases
and 55 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on GRAL insider trades is 59.8/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest GRAL Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for GRAL?
- FilingIQ tracks 107 Form 4 insider transactions for GRAL (GRAIL, Inc.), covering filings from Jun 24, 2024 onwards. 23 of those were filed in the last 90 days.
- Are GRAL insiders net buyers or net sellers?
- Across the full Form 4 history for GRAL, 4 transactions (4%) were open-market purchases and 55 (51%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does GRAL insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is GRAL in?
- GRAIL, Inc. (GRAL) is classified in the Healthcare sector, specifically Diagnostics & Research, with a current market capitalisation of $2.14B.
Methodology & sources
Every GRAL insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.